• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited communit

tetano

Editor, Senior Moderator
Euro Surveill. 2020 Mar;25(11). doi: 10.2807/1560-7917.ES.2020.25.11.2000230.
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020.


Nicastri E[SUP]1,[/SUP][SUP]2[/SUP], D'Abramo A[SUP]1,[/SUP][SUP]2[/SUP], Faggioni G[SUP]3[/SUP], De Santis R[SUP]3[/SUP], Mariano A[SUP]2[/SUP], Lepore L[SUP]2[/SUP], Molinari F[SUP]3[/SUP], Petralito G[SUP]3[/SUP], Fillo S[SUP]3[/SUP], Munzi D[SUP]3[/SUP], Corpolongo A[SUP]2[/SUP], Bordi L[SUP]2[/SUP], Carletti F[SUP]2[/SUP], Castiletti C[SUP]2[/SUP], Colavita F[SUP]2[/SUP], Lalle E[SUP]2[/SUP], Bevilacqua N[SUP]2[/SUP], Giancola ML[SUP]2[/SUP], Scorzolini L[SUP]2[/SUP], Lanini S[SUP]2[/SUP], Palazzolo C[SUP]2[/SUP], De Domenico A[SUP]4[/SUP], Spinelli MA[SUP]3[/SUP], Scognamiglio P[SUP]2[/SUP], Piredda P[SUP]4[/SUP], Iacomino R[SUP]4[/SUP], Mone A[SUP]4[/SUP], Puro V[SUP]2[/SUP], Petrosillo N[SUP]2[/SUP], Battistini A[SUP]5[/SUP], Vairo F[SUP]2[/SUP], Lista F[SUP]6,[/SUP][SUP]3[/SUP], Ippolito G[SUP]6,[/SUP][SUP]2[/SUP], On Behalf Of Inmi And The Italian Army Covid-Study Groups[SUP]7[/SUP].

Author information




Abstract

Data concerning the transmission of the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) in paucisymptomatic patients are lacking. We report an Italian paucisymptomatic case of coronavirus disease 2019 with multiple biological samples positive for SARS-CoV-2. This case was detected using the World Health Organization protocol on cases and contact investigation. Current discharge criteria and the impact of extra-pulmonary SARS-CoV-2 samples are discussed.



KEYWORDS:

COVID-19; Italy; paucisymptomatic case


PMID:32209164DOI:10.2807/1560-7917.ES.2020.25.11.2000230
 
Back
Top